BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Orthogon Therapeutics Secures 11 Million Dollars To Advance First In Class Oral Therapy For BK Virus In Transplant Patients

Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...

April 21, 2026 | News

Avantor Expands St Louis Quality Control Capabilities To Accelerate Biopharma Manufacturing

St. Louis site strengthens integrated support for biopharma manufacturing Avantor, Inc, a leading global provider of mission-critical products and ser...

April 20, 2026 | News

Oricell Therapeutics Raises Over USD 110 Million To Accelerate Global CAR T Innovation

Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, announc...

April 13, 2026 | News

Vivatides Secures USD 54 Million Series A To Advance Next Generation RNA Therapeutics Beyond Liver Targets

Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...

April 13, 2026 | News

Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal

Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate considera...

April 09, 2026 | News

Insilico Medicine And Eli Lilly Enter AI Led Drug Discovery Collaboration With Multibillion Dollar Potential

AI-driven collaboration includes an exclusive worldwide license for a portfolio of programs spanning multiple therapeutic areas. Insilico Medicine ("Insil...

March 31, 2026 | News

Thermo Fisher Accelerates Clinical Intelligence Leadership With Strategic Clario Acquisition

Further strengthens Thermo Fisher’s position as the trusted partner to pharma and biotech customers, delivering important customer benefits Attracti...

March 25, 2026 | News

SK Pharmteco Commits 100 Million Dollars To Strengthen Viral Vector Capabilities And Multi Modality CDMO Strategy

SK pharmteco announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term ...

March 20, 2026 | News

Curatis Partners With Neupharma To Advance Corticorelin Development For Brain Tumour Related Edema In Japan

Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developi...

March 12, 2026 | News

Japan Launches Elevidys Gene Therapy For Young Children With Duchenne Muscular Dystrophy

- Japan now offers ELEVIDYS gene therapy to children with Duchenne muscular dystrophy aged 3 years to less than 8 years - Company is eligible ...

February 27, 2026 | News

Sciwind Biosciences And Pfizer China Forge Strategic Commercialisation Pact For Ecnoglutide In Mainland China

Hangzhou Sciwind Biosciences Co., Ltd. announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a n...

February 25, 2026 | News

Pharmacelera Secures €6 Million To Expand US Footprint And Advance Quantum AI Drug Discovery Platform

Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoi...

February 19, 2026 | News

Lupin Launches Topiramate Extended Release Capsules In The United States

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the launch of Topira...

February 06, 2026 | News

Insilico Medicine Receives $5 Million Milestone From Menarini Group After First Patient Dosed In Phase 1 Trial Of AI Designed Cancer Therapy

Followed by the development and regulatory milestone payment of USD 3 million in July 2025, Insilico received an additional milestone paymen...

February 05, 2026 | News

Stay Connected